Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Erik LaChance"'
Autor:
Kellie Arensman, Jessica L. Miller, Anthony Chiang, Nathan Mai, Joseph Levato, Erik LaChance, Morgan Anderson, Maya Beganovic, Jennifer Dela Pena
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 5, Pp 876-880 (2020)
Candida auris is an emerging fungal pathogen that is typically resistant to fluconazole and is known to cause healthcare-associated outbreaks. We retrospectively reviewed 28 patients who had >1 positive culture for C. auris within a multisite health
Externí odkaz:
https://doaj.org/article/c5d730381f9144a5bc72291bef572940
Publikováno v:
IDCases, Vol 21, Iss , Pp e00819- (2020)
Influenza is an annual epidemic disease that in severe cases can lead to the development of ARDS. Current practice recommends the routine use of neuraminidase inhibitors with emerging evidence for the use of endonuclease inhibitors. We present the ca
Externí odkaz:
https://doaj.org/article/db34554e8d704ff882ddc53f3e82df23
Autor:
Joseph Levato, Maya Beganovic, Anthony Chiang, Erik LaChance, Jessica L Miller, Nathan Mai, Jennifer Dela Pena, Kellie Arensman, Morgan Anderson
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 5, Pp 876-880 (2020)
Emerging Infectious Diseases
Emerging Infectious Diseases
Candida auris is an emerging fungal pathogen that is typically resistant to fluconazole and is known to cause healthcare-associated outbreaks. We retrospectively reviewed 28 patients who had >1 positive culture for C. auris within a multisite health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d396ee860d792b0de617a781634f504
https://wwwnc.cdc.gov/eid/article/26/5/19-1588_article
https://wwwnc.cdc.gov/eid/article/26/5/19-1588_article
Autor:
Maya Beganovic, Morgan Anderson, Maureen Shields, Kellie Arensman, Jennifer Dela-Pena, Erik LaChance, Jessica L Miller
Publikováno v:
Antimicrob Agents Chemother
Fluoroquinolones (FQs) are often preferred as oral step-down therapy for bloodstream infections (BSIs) due to favorable pharmacokinetic parameters; however, they are also associated with serious adverse events. The objective of this study was to comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0af9a66979a1f62bdadad5b702f102
https://europepmc.org/articles/PMC7577143/
https://europepmc.org/articles/PMC7577143/
Autor:
Sarah M. Wieczorkiewicz, Maya Beganovic, Jennifer Dela-Pena, Anne Rivelli, Erik LaChance, Kellie Arensman, Jessica L Miller, Morgan Anderson
Publikováno v:
Open Forum Infectious Diseases. 7
Background The purpose of this study was to evaluate the impact of infectious diseases consultation (IDC) and a real-time antimicrobial stewardship (AMS) review on the management of Staphylococcus aureus bacteremia (SAB). Methods This retrospective s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e4c0b3c491083578debd97901b94266
https://doi.org/10.1093/ofid/ofaa184
https://doi.org/10.1093/ofid/ofaa184
Publikováno v:
IDCases
IDCases, Vol 21, Iss, Pp e00819-(2020)
IDCases, Vol 21, Iss, Pp e00819-(2020)
Highlights • Baloxavir is an antiviral influenza medication with a different mechanism of action and its use in combination with oseltamivir has not been reported on patients with severe renal impairment. • Immunocompromise patients have a tenden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a9ea02eb72d8edbace8c6d7726ba4c
http://europepmc.org/articles/PMC7256313
http://europepmc.org/articles/PMC7256313
Autor:
Kellie, Arensman, Jennifer, Dela-Pena, Jessica L, Miller, Erik, LaChance, Maya, Beganovic, Morgan, Anderson, Anne, Rivelli, Sarah M, Wieczorkiewicz
Publikováno v:
Open Forum Infectious Diseases
Background The purpose of this study was to evaluate the impact of infectious diseases consultation (IDC) and a real-time antimicrobial stewardship (AMS) review on the management of Staphylococcus aureus bacteremia (SAB). Methods This retrospective s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1146a1df00a90cd05bd4c2d94fb40a2c
https://pubmed.ncbi.nlm.nih.gov/32548206
https://pubmed.ncbi.nlm.nih.gov/32548206
Autor:
Sarah M. Wieczorkiewicz, Kellie Arensman, Morgan Anderson, Jessica L Miller, Erik LaChance, Jennifer Dela-Pena, Maya Beganovic
Publikováno v:
Open Forum Infectious Diseases
Background Infectious diseases consult (IDC) and antimicrobial stewardship (AMS) intervention independently demonstrate improved management of Staphylococcus aureus bacteremia (SAB). However, data supporting utilizing both strategies is limited. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4486330dfd7b06f6fdca096e4b555bfc
http://europepmc.org/articles/PMC6811310
http://europepmc.org/articles/PMC6811310
Autor:
Imad Almanaseer, Leo Kelly, Jay Watson, Erik LaChance, Jessica Miller, Angelica Whaley, Robert J. Citronberg, Sarah M. Wieczorkiewicz
Publikováno v:
Open Forum Infectious Diseases
Background Since the implementation of more sensitive molecular diagnostics such as the Clostridium difficile PCR assay, hospitals have reported 50–100% increases in C. difficile infection (CDI) rates. Methods This single-center, quasi-experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ae713a7cf094c3ec296e2290c425cf
http://europepmc.org/articles/PMC6253179
http://europepmc.org/articles/PMC6253179
Autor:
Anthony Chiang, Sarah M. Wieczorkiewicz, Jennifer Dela-Pena, Jessica L Miller, Erik LaChance, Morgan Anderson, Maya Beganovic, Kelvin Gandhi
Publikováno v:
Open Forum Infectious Diseases
Background The Clinical and Laboratory Standards Institute (CLSI) lowered the minimum inhibitory concentration (MIC) breakpoints of various β-lactam antimicrobials eliminating the need for confirmatory testing of extended-spectrum β-lactamase (ESBL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8cf9417b8cb87b98654623b7dc79d23
http://europepmc.org/articles/PMC6811015
http://europepmc.org/articles/PMC6811015